The innovative medicine sector rose, with Cube Pharmaceuticals having 3 consecutive shares, Harbin Pharmaceutical Co., Ltd. 2. Longshen Rongfa and Wanbang Pharmaceutical rose more than 10%, while Xintiandi, Eling Pharmaceutical, Shuanglu Pharmaceutical, Haofan Biotech, and Haizheng Pharmaceutical followed suit.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.